Literature DB >> 11244465

Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men.

N F Chu1, M J Stampfer, D Spiegelman, N Rifai, G S Hotamisligil, E B Rimm.   

Abstract

OBJECTIVE: Leptin, the product of the obesity (ob) gene, is a multi-functional polypeptide that is important in energy metabolism, which is strongly correlated with body fat mass and body mass index (BMI). In a recent prospective study, we found that leptin was positively associated with 4 y weight gain among overweight and obese men. This suggests that leptin resistance, marked by hyperleptinemia among obese subjects, may be an important marker for weight gain. The purpose of this study is to evaluate whether modifiable dietary and lifestyle factors are associated with plasma leptin concentrations among US men.
METHODS: We included 268 men aged 47--83 y (who were free of cardiovascular disease, diabetes mellitus and cancer, except nonmelanoma skin cancer) from the ongoing Health Professionals Follow-up Study. These subjects completed a detailed dietary and lifestyle questionnaire (including cigarette smoking, alcohol drinking and physical activity) and provided a fasting venous blood sample in 1994. All blood samples were stored in a deep freeze (-70 degrees C) for 4--5 y before being analyzed. Plasma leptin concentrations were measured by radioimmunoassay.
RESULTS: Men in the highest quintile of plasma leptin (mean=14.4 ng/ml) weighed more, were less physically active, and had higher total and saturated fat and cholesterol intake than men in the lowest quintile (mean=3.0 ng/ml). Physical activity and current smoking were inversely associated with plasma leptin concentrations (P<0.001). A 20 MET difference in physical activity per week (equivalent to approximately 3 h of jogging) was associated with 0.38--0.58 ng/ml lower plasma leptin concentrations for normal weight and overweight men after adjusting for total energy and fat intake, BMI and other confounding variables. Total fat and monounsaturated fat intakes were positively associated with plasma leptin concentrations even after adjusting for BMI and other confounding variables; however, this association was limited to men of normal weight (BMI<25 kg/m(2)).
CONCLUSION: These data suggest that physical activity may be a significant determinant of plasma leptin concentrations in men. Increasing physical activity is associated with lower plasma leptin concentrations even after adjusting for BMI. Physical activity may lower leptin concentrations not only due to decreased body fat mass, but potentially through an increase in leptin sensitivity. International Journal of Obesity (2001) 25, 106-114

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244465     DOI: 10.1038/sj.ijo.0801468

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  22 in total

1.  Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.

Authors:  Shehab M Abd El-Kader; Fadwa M Al-Shreef; Osama H Al-Jiffri
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

2.  Do genetic risk scores for body mass index predict risk of phobic anxiety? Evidence for a shared genetic risk factor.

Authors:  S Walter; M M Glymour; K Koenen; L Liang; E J Tchetgen Tchetgen; M Cornelis; S-C Chang; M Rewak; E Rimm; I Kawachi; L D Kubzansky
Journal:  Psychol Med       Date:  2014-05-28       Impact factor: 7.723

3.  Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin Study.

Authors:  Jacqueline Pontes Monteiro; Carolyn Wise; Melissa J Morine; Candee Teitel; Lisa Pence; Anna Williams; Beverly McCabe-Sellers; Catherine Champagne; Jerome Turner; Beatrice Shelby; Baitang Ning; Joan Oguntimein; Lauren Taylor; Terri Toennessen; Corrado Priami; Richard D Beger; Margaret Bogle; Jim Kaput
Journal:  Genes Nutr       Date:  2014-04-24       Impact factor: 5.523

4.  Psychological wellbeing and biochemical modulation in response to weight loss in obese type 2 diabetes patients.

Authors:  Al-Jiffri Osama; Abd El-Kader Shehab
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

5.  Relation of dietary and lifestyle traits to difference in serum leptin of Japanese in Japan and Hawaii: the INTERLIPID study.

Authors:  Y Nakamura; H Ueshima; N Okuda; K Miura; Y Kita; T Okamura; T C Turin; A Okayama; B Rodriguez; J D Curb; J Stamler
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-08-03       Impact factor: 4.222

6.  Diet quality is associated with circulating C-reactive protein but not irisin levels in humans.

Authors:  Kyung Hee Park; Lesya Zaichenko; Patricia Peter; Cynthia R Davis; Judith A Crowell; Christos S Mantzoros
Journal:  Metabolism       Date:  2013-10-29       Impact factor: 8.694

7.  Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).

Authors:  Jeannette M Beasley; Brett A Ange; Cheryl A M Anderson; Edgar R Miller Iii; Janet T Holbrook; Lawrence J Appel
Journal:  Obesity (Silver Spring)       Date:  2008-12-04       Impact factor: 5.002

8.  Higher habitual intake of dietary fat and carbohydrates are associated with lower leptin and higher ghrelin concentrations in overweight and obese postmenopausal women with elevated insulin levels.

Authors:  Angela Kong; Marian L Neuhouser; Liren Xiao; Cornelia M Ulrich; Anne McTiernan; Karen E Foster-Schubert
Journal:  Nutr Res       Date:  2009-11       Impact factor: 3.315

9.  Serum leptin level and cognition in the elderly: Findings from the Health ABC Study.

Authors:  Karen F Holden; Karla Lindquist; Frances A Tylavsky; Caterina Rosano; Tamara B Harris; Kristine Yaffe
Journal:  Neurobiol Aging       Date:  2008-03-20       Impact factor: 4.673

10.  Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population.

Authors:  Vijay Ganji; Mohammad R Kafai; Erin McCarthy
Journal:  Nutr Metab (Lond)       Date:  2009-01-14       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.